In HCC and gastric cancer, dysregulated NF-κB signaling has been consistently linked to enhanced tumor cell proliferation and chemoresistance, whereas pharmacological inhibition of NF-κB has been shown to augment the therapeutic efficacy of 5-FU [360]. The gene discussed is NFKB1; the disease is gastric cancer.